<?xml version='1.0' encoding='utf-8'?>
<document id="27310200"><sentence text="Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant Patients." /><sentence text="Sirolimus is a mammalian target of rapamycin inhibitor that is being used to prevent organ rejection in kidney transplant patients often in combination with calcineurin inhibitors (CNIs; cyclosporine and tacrolimus)"><entity charOffset="0-9" id="DDI-PubMed.27310200.s2.e0" text="Sirolimus" /><entity charOffset="35-44" id="DDI-PubMed.27310200.s2.e1" text="rapamycin" /><entity charOffset="187-199" id="DDI-PubMed.27310200.s2.e2" text="cyclosporine" /><entity charOffset="204-214" id="DDI-PubMed.27310200.s2.e3" text="tacrolimus" /><pair ddi="false" e1="DDI-PubMed.27310200.s2.e0" e2="DDI-PubMed.27310200.s2.e0" /><pair ddi="false" e1="DDI-PubMed.27310200.s2.e0" e2="DDI-PubMed.27310200.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27310200.s2.e0" e2="DDI-PubMed.27310200.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27310200.s2.e0" e2="DDI-PubMed.27310200.s2.e3" /><pair ddi="false" e1="DDI-PubMed.27310200.s2.e1" e2="DDI-PubMed.27310200.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27310200.s2.e1" e2="DDI-PubMed.27310200.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27310200.s2.e1" e2="DDI-PubMed.27310200.s2.e3" /><pair ddi="false" e1="DDI-PubMed.27310200.s2.e2" e2="DDI-PubMed.27310200.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27310200.s2.e2" e2="DDI-PubMed.27310200.s2.e3" /></sentence><sentence text=" All 3 drugs are metabolized primarily by CYP3As" /><sentence text=" Clinical drug-drug interaction (DDI) studies of cyclosporine on sirolimus pharmacokinetics have been reported; however, there are a few clinical DDI data related to tacrolimus"><entity charOffset="49-61" id="DDI-PubMed.27310200.s4.e0" text="cyclosporine" /><entity charOffset="65-74" id="DDI-PubMed.27310200.s4.e1" text="sirolimus" /><entity charOffset="166-176" id="DDI-PubMed.27310200.s4.e2" text="tacrolimus" /><pair ddi="false" e1="DDI-PubMed.27310200.s4.e0" e2="DDI-PubMed.27310200.s4.e0" /><pair ddi="false" e1="DDI-PubMed.27310200.s4.e0" e2="DDI-PubMed.27310200.s4.e1" /><pair ddi="false" e1="DDI-PubMed.27310200.s4.e0" e2="DDI-PubMed.27310200.s4.e2" /><pair ddi="false" e1="DDI-PubMed.27310200.s4.e1" e2="DDI-PubMed.27310200.s4.e1" /><pair ddi="false" e1="DDI-PubMed.27310200.s4.e1" e2="DDI-PubMed.27310200.s4.e2" /></sentence><sentence text="" /><sentence text="In vitro inhibition assay with sirolimus were conducted using recombinant CYP3As and human microsomes in the presence and absence of CNIs"><entity charOffset="31-40" id="DDI-PubMed.27310200.s6.e0" text="sirolimus" /></sentence><sentence text=" Sirolimus concentrations were determined by validated high-performance liquid chromatography-tandem mass spectrometry (LC/MS-MS) assay" /><sentence text=" The DDI risk in terms of increase in sirolimus area under the curve (AUC) was evaluated by a mechanistic model using in vitro inhibition data and published pharmacokinetic parameters of CNIs" /><sentence text="" /><sentence text="Both CNIs showed similar inhibitory effects on sirolimus metabolism in human liver and intestinal microsomes"><entity charOffset="47-56" id="DDI-PubMed.27310200.s10.e0" text="sirolimus" /></sentence><sentence text=" Cyclosporine predominantly inhibited CYP3A4 (half maximal inhibitory concentration = 0"><entity charOffset="1-13" id="DDI-PubMed.27310200.s11.e0" text="Cyclosporine" /></sentence><sentence text="71 µM) rather than CYP3A5 (&gt;5 µM), whereas tacrolimus showed similar inhibition for CYP3A4 (0" /><sentence text="29 µM) and CYP3A5 (0" /><sentence text="41 µM)" /><sentence text=" The predicted increase in AUC of sirolimus during the coadministration of cyclosporine was 3"><entity charOffset="34-43" id="DDI-PubMed.27310200.s15.e0" text="sirolimus" /><entity charOffset="75-87" id="DDI-PubMed.27310200.s15.e1" text="cyclosporine" /><pair ddi="false" e1="DDI-PubMed.27310200.s15.e0" e2="DDI-PubMed.27310200.s15.e0" /><pair ddi="false" e1="DDI-PubMed.27310200.s15.e0" e2="DDI-PubMed.27310200.s15.e1" /></sentence><sentence text="9-fold, which was comparable to the observed clinical data (3" /><sentence text="3-fold) in healthy volunteers" /><sentence text=" Sirolimus AUC was estimated to a 2" /><sentence text="8- to 3" /><sentence text="2-fold increase during the coadministration of tacrolimus, based on the reported Cmax values and doses of tacrolimus in kidney transplant patients"><entity charOffset="47-57" id="DDI-PubMed.27310200.s20.e0" text="tacrolimus" /><entity charOffset="106-116" id="DDI-PubMed.27310200.s20.e1" text="tacrolimus" /><pair ddi="false" e1="DDI-PubMed.27310200.s20.e0" e2="DDI-PubMed.27310200.s20.e0" /><pair ddi="false" e1="DDI-PubMed.27310200.s20.e0" e2="DDI-PubMed.27310200.s20.e1" /></sentence><sentence text=" In addition, exploratory sensitivity analysis indicated that the predicted increase in sirolimus AUC was sensitive to the free fraction of cyclosporine but not to the free fraction of tacrolimus"><entity charOffset="140-152" id="DDI-PubMed.27310200.s21.e0" text="cyclosporine" /><entity charOffset="185-195" id="DDI-PubMed.27310200.s21.e1" text="tacrolimus" /><pair ddi="false" e1="DDI-PubMed.27310200.s21.e0" e2="DDI-PubMed.27310200.s21.e0" /><pair ddi="false" e1="DDI-PubMed.27310200.s21.e0" e2="DDI-PubMed.27310200.s21.e1" /></sentence><sentence text="" /><sentence text="This study suggests that tacrolimus has a lower clinical DDI risk potential affecting sirolimus pharmacokinetics compared with cyclosporine in kidney transplant patients"><entity charOffset="25-35" id="DDI-PubMed.27310200.s23.e0" text="tacrolimus" /><entity charOffset="86-95" id="DDI-PubMed.27310200.s23.e1" text="sirolimus" /><entity charOffset="127-139" id="DDI-PubMed.27310200.s23.e2" text="cyclosporine" /><pair ddi="false" e1="DDI-PubMed.27310200.s23.e0" e2="DDI-PubMed.27310200.s23.e0" /><pair ddi="false" e1="DDI-PubMed.27310200.s23.e0" e2="DDI-PubMed.27310200.s23.e1" /><pair ddi="false" e1="DDI-PubMed.27310200.s23.e0" e2="DDI-PubMed.27310200.s23.e2" /><pair ddi="false" e1="DDI-PubMed.27310200.s23.e1" e2="DDI-PubMed.27310200.s23.e1" /><pair ddi="false" e1="DDI-PubMed.27310200.s23.e1" e2="DDI-PubMed.27310200.s23.e2" /></sentence><sentence text="" /></document>